Esperante BV
General contacts
Investor type
PE
Founded
2004
AUM
-
Location
Netherlands
Investor profile last updated: 11 October, 2021
Profile
Esperante is a venture investment company controlled by C&P Group Holdings, a privately controlled life science interests group. The management, Board of Directors, Investment Committee and Advisors are significantly experienced in the operational management of life science companies, with a particular focus on the development, manufacturing and marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests on a worldwide basis.
Industry
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Esperante BV — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Esperante BV
Is Esperante BV a venture capital or private equity firm?
Esperante BV is a private equity firm. It backs companies at Seed and Series A, writing tickets of $1-5 m.
Where is Esperante BV located?
Esperante BV is located in Netherlands.
When was Esperante BV founded?
Esperante BV was founded in 2004.
What sectors and industries does Esperante BV invest in?
Esperante BV invests in companies and startups in Healthcare Services, Other, Pharmaceuticals, Biotechnology, MedTech, Life Sciences, HealthTech.
What is Esperante BV geographical focus of investments?
Esperante BV invests in companies and startups in Europe.
At what stages of companies and startups does Esperante BV typically invest in?
Esperante BV invests in companies and startups at Seed, Series A.
What is the usual amount of Esperante BV investment?
Esperante BV usually invests $1-5 m on average.
What are the contacts of Esperante BV?
Esperante BV can be reached through its website esperanteventures.com and its LinkedIn page. Its general enquiries address is dslagel@esperanteventures.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Esperante BV — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Esperante BV data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Esperante BV directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Esperante BV profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 11 October, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.